Non-invasive Optical Tissue Analysis for Scar Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for evaluating collagen concentration in tissues are invasive, time-consuming, and costly, and fail to accurately differentiate between hypertrophic scars, keloids, and normal scars, which hinders effective treatment modalities.

Innovation Solution

A non-invasive optical system using a multi-wavelength light source to illuminate tissues, detecting diffuse reflectance spectra, and converting them into absorption spectra to derive concentrations of chromophores like collagen, melanin, hemoglobin, and water through a specific equation, allowing for quick and accurate collagen concentration measurement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If slide examination is used to evaluate component concentrations in tissues, then measurement precision is improved, but invasiveness increases causing wounds and scars

Engineering Contradiction:
Improvecomponent concentration evaluationVSAvoidwound and scar formation
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical invasive slide examination system with a non-invasive optical detection system. Specifically, it uses diffuse reflectance spectroscopy to measure tissue optical properties and derives component concentrations (collagen, elastin, water, lipids, proteins) without physical tissue extraction, thereby eliminating wounds and scars while maintaining measurement capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces optical properties (absorption and scattering coefficients) as intermediary parameters that can be non-invasively measured and then converted into component concentration information. The optical properties serve as a mediator between the non-invasive measurement and the desired compositional data, allowing indirect but accurate evaluation of tissue components

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If multi-photon microscopy is used to obtain structural information, then measurement precision is improved, but measurement time increases and system cost increases

Engineering Contradiction:
Improvetissue structural informationVSAvoidmeasurement time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent extracts only the essential optical properties (absorption and scattering coefficients) needed for component concentration evaluation, rather than using the full complexity of multi-photon microscopy. By focusing on diffuse reflectance spectroscopy and deriving concentrations from optical properties, it obtains sufficient structural and compositional information with reduced measurement time and lower system cost

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the measurement parameters from complex multi-photon imaging to simpler diffuse reflectance spectroscopy measurements. It measures optical properties at specific wavelengths and uses spectral unmixing to derive component concentrations, thereby achieving efficient evaluation with shorter measurement time and reduced system complexity

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If conventional detection methods are used to identify scar types, then measurement precision is improved, but adaptability decreases due to inability to differentiate hypertrophic scars and keloids

Engineering Contradiction:
Improvescar type identificationVSAvoiddifferentiation capability
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent adds spectral dimension to scar characterization by measuring optical properties across multiple wavelengths and analyzing the spectral signatures of different components. It uses the ratios and patterns of component concentrations (particularly collagen, elastin, and water) to differentiate between hypertrophic scars and keloids, providing enhanced adaptability for various scar type identification

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent creates a universal detection system that can evaluate multiple tissue components (collagen, elastin, water, lipids, proteins) and apply to various scar types and potentially other tissue conditions. The same optical measurement and spectral unmixing approach works for differentiating hypertrophic scars, keloids, and normal skin, demonstrating versatility across multiple diagnostic applications

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables accurate, non-invasive, and cost-effective evaluation of collagen concentration and distribution in tissues, effectively distinguishing between hypertrophic scars, keloids, and normal scars, with potential applications in skin disease diagnosis and cosmetic dermatology.

Implementation Method 1

detecting reflected light from the tested tissue with a detector in multiple directions to obtain diffuse reflectance spectra

Methodology Applied
Scientific EffectDiffuse reflectance: Reflection

Implementation Method 2

converting the diffuse reflectance spectra into absorption spectra; and fitting the absorption spectra with known chromophore absorption spectra to derive concentrations of components

Methodology Applied
Scientific EffectAbsorption spectroscopy: Absorption Spectroscopy

Data Source

PatentUS9345431B2Method and optical system for evaluating concentrations of components in tissue
Publication Date: 2016.05.24 NAT CHENG KUNG UNIV
  • US9345431B2 patent drawing
  • US9345431B2 patent drawing
  • US9345431B2 patent drawing

AI summary

A method and an optical system for evaluating the spatial distribution of the concentrations of components in tissue are disclosed. The novel detecting probe included in the optical system comprises plural optical fiber sets, each optical fiber set respectively comprises at least one source optical fiber and at least one detector optical fiber, the source optical fiber connects with the multi-wavelength light source, the source optical fiber delivers light from the multi-wavelength light source onto a tested tissue; and the angle between one optical fiber set and another optical fiber set is greater than 0° and less than and not equal to 180°. Through the optical system of the present invention, the spatial distribution of the concentrations of components such as water, hemoglobin, melanin, lipid, and collagen in the tested tissue can be derived by an equation (I) defined in the present specification.